Faculty Digital Archive

Archive@NYU >
Stern School of Business >
IOMS: Information Systems Working Papers >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2451/14269

Title: RE-ENGINEERING TRADING AND TREASURY OPERATIONS IN INTERNATIONAL FINANCIAL SERVICES
Authors: Dhar, Vasant
Duliba, Katherine A.
Kauffman, Robert J.
Issue Date: 30-Jun-1993
Publisher: Stern School of Business, New York University
Series/Report no.: IS-93-35
Abstract: Maximizing business value of investments in hardware, software and telecommunications technologies that occur in the trading and treasury operations of an international bank requires senior management to evaluate the extent to which the technology infrastructure enables the bank to perform a number of key functions. These include: formulating effective trading strategies, pricing financial instruments accurately and rapidly, being able to respond to changing market conditions, processing transactions cost-effectively, resolving inquiries quickly, and moving to support emerging corporate treasury products. After a decade of rapid growth in investment levels, senior managers now emphasize refining, rationalizing and integrating trading and treasury technology architectures to support improved global financial risk management, better capital utilization, and higher transaction volumes. This chapter examines how senior managers can accomplish these goals by re-engineering pre-trade, trade execution and post-trade business processes. It presents a framework that utilizes basic concepts from management science and microeconomics to illustrate the variety of impacts that re-engineering can have on improving firm revenues and controlling or reducing costs. It also presents a series of managerial recommendations based on the framework.
URI: http://hdl.handle.net/2451/14269
Appears in Collections:IOMS: Information Systems Working Papers

Files in This Item:

File Description SizeFormat
IS-93-35.pdf7.45 MBAdobe PDFView/Open

Items in Faculty Digital Archive are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The contents of the FDA may be subject to copyright, be offered under a Creative Commons license, or be in the public domain.
Please check items for rights statements. For information about NYU’s copyright policy, see http://www.nyu.edu/footer/copyright-and-fair-use.html 
Valid XHTML 1.0 | CSS